Correlation Between Bio Techne and Alnylam Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Bio Techne and Alnylam Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Techne and Alnylam Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bio Techne and Alnylam Pharmaceuticals,, you can compare the effects of market volatilities on Bio Techne and Alnylam Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Techne with a short position of Alnylam Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Techne and Alnylam Pharmaceuticals,.

Diversification Opportunities for Bio Techne and Alnylam Pharmaceuticals,

0.12

Correlation Coefficient

Bio Techne  Alnylam Pharmaceuticals,

Average diversification

The 3 months correlation between Bio and Alnylam is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne and Alnylam Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals, and Bio Techne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Techne are associated (or correlated) with Alnylam Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals, has no effect on the direction of Bio Techne i.e., Bio Techne and Alnylam Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Bio Techne and Alnylam Pharmaceuticals,

Assuming the 90 days trading horizon Bio Techne is expected to generate 2.45 times less return on investment than Alnylam Pharmaceuticals,. In addition to that, Bio Techne is 1.9 times more volatile than Alnylam Pharmaceuticals,. It trades about 0.06 of its total potential returns per unit of risk. Alnylam Pharmaceuticals, is currently generating about 0.27 per unit of volatility. If you would invest  6,944  in Alnylam Pharmaceuticals, on April 24, 2025 and sell it today you would earn a total of  1,630  from holding Alnylam Pharmaceuticals, or generate 23.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Bio Techne  vs.  Alnylam Pharmaceuticals,

Bio Techne

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bio Techne are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Bio Techne may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Alnylam Pharmaceuticals,

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals, are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, Alnylam Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bio Techne and Alnylam Pharmaceuticals,

The main advantage of trading using opposite Bio Techne and Alnylam Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Techne position performs unexpectedly, Alnylam Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals, will offset losses from the drop in Alnylam Pharmaceuticals,'s long position.

The idea behind Bio Techne and Alnylam Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.